Suppr超能文献

肾功能和肾体积对常染色体显性多囊肾病患者颅内动脉瘤的影响。

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease.

机构信息

Department of Nephrology, Tokyo Women's Medical University, 8-1 Kawada-Cho, Shinjuku-Ku, Tokyo, 162-8666, Japan.

Clinical Research Division for Polycystic Kidney Disease, Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Sci Rep. 2022 Oct 27;12(1):18056. doi: 10.1038/s41598-022-22884-9.

Abstract

Presently, only personal or family history of intracranial aneurysm/subarachnoid hemorrhage (IA/SAH) has been established as a risk factor for IA in autosomal dominant polycystic kidney disease (ADPKD). This study aimed to verify the association between kidney function/volume and IAs in patients with ADPKD. This study included 519 patients with ADPKD. At baseline IA screening, the median age and estimated glomerular filtration rate were 44 years and 54.5 mL/min/1.73 m, respectively. Family IA/SAH history was confirmed in 18.1% of the patients, and 54.3% of the patients had hypertension. The IA point prevalence was 12.5%. During clinical follow up of 3104 patient-years, de novo IA was detected in 29 patients (0.93% patient-years). The IA period prevalence was 18.1% (median age, 60 years). Multivariable logistic regression demonstrated that total kidney volume (TKV) ≥ 1000 mL (odds ratio [OR] = 2.81), height-adjusted TKV ≥ 500 mL (OR = 2.81), Mayo imaging classification Class 1D-1E (OR = 2.52), and chronic kidney disease stages 3-5 (OR = 2.31) were significantly associated with IA formation. IAs in patients with ADPKD may be associated not only with general risk factors for IAs but also with declining kidney function and increased KV. Kidney disease progression may contribute to effective IA screening and treatment planning in patients with ADPKD.

摘要

目前,仅有颅内动脉瘤/蛛网膜下腔出血(IA/SAH)的个人或家族史被确定为常染色体显性多囊肾病(ADPKD)中 IA 的危险因素。本研究旨在验证 ADPKD 患者的肾功能/体积与 IA 之间的关联。本研究纳入了 519 名 ADPKD 患者。在 IA 筛查的基线时,中位年龄和估算肾小球滤过率分别为 44 岁和 54.5 mL/min/1.73 m。18.1%的患者有 IA/SAH 家族史,54.3%的患者患有高血压。IA 的现患率为 12.5%。在 3104 患者年的临床随访期间,29 名患者(0.93%患者年)新检出 IA。IA 的期间现患率为 18.1%(中位年龄 60 岁)。多变量逻辑回归显示总肾体积(TKV)≥1000 mL(比值比[OR] = 2.81)、身高校正的 TKV≥500 mL(OR = 2.81)、Mayo 影像学分类 1D-1E 级(OR = 2.52)和慢性肾脏病 3-5 期(OR = 2.31)与 IA 形成显著相关。ADPKD 患者的 IA 不仅可能与 IA 的一般危险因素相关,还可能与肾功能下降和 KV 增加相关。肾脏疾病的进展可能有助于对 ADPKD 患者进行有效的 IA 筛查和治疗计划。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/984e/9613770/06acf1112245/41598_2022_22884_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验